For more than 100 years, Delaware has been America’s favorite place to do business. About 68% of all Fortune 500 companies are incorporated in Delaware, and 93% of all U.S.-based […]
Ardent’s technology is key to reducing the cost of gas separation, making it more economically feasible for companies to reduce CO2 emissions.
With the word “potential” in its name, OmniPotential Energy Partners is working to address the challenge many potential owners of electric vehicles face —specifically the ability to conveniently “fuel” one.
Cellergy Pharma is working to cure severe allergic diseases, including two large, underserved severe allergic disease markets (uncontrollable severe allergic asthma and severe food allergy), by using novel cancer-fighting CAR T cells that target and ...
Two biotech powerhouses joined forces in January 2024, when Delaware-based Incyte teamed up with Agilent, a leader in the field of companion diagnostic assays to detect biomarkers of disease, to support the development and commercialization ...
Technological advances occur in each of Delaware’s key industries and span a variety of markets, including pharmaceuticals, industrial and agricultural chemicals, medical devices, computer services and more, according to the Delaware Prosperity Partnership.
Almost a decade ago, when Dr. Milton Muldrow first came to Wilmington University, there were no science programs avail-able for undergraduate or graduate students.
Expanding opportunities for students is a key goal at Delaware State University (DSU), Delaware’s Historically Black College or University (HBCU).
As America explores clean energy options to secure the country’s climate future, offshore wind farms are a key part of the conversation all along the East Coast.
The demand for biopharmaceutical products is on the rise. It is expected that within 10 years, up to 50% of all drugs in development will be biopharmaceutical.
Premier Digital Partners
© 2024 Delaware Business Times
